Compliance Claim Guidance Being Considered By FDA - DDMAC's Palmer

Promotional "compliance claims" may be the next subject tackled in a draft guidance from FDA's Division of Drug Marketing, Advertising & Communications, Branch Chief Leah Palmer told the Drug Information Association annual meeting.